Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

WURTH EXPANDABLE FOAM

NFPA

PRODUCT USE

Application is by spray atomization from a hand held aerosol pack. Expandable foam.

SYNONYMS

"expandable foam"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

Harmful by inhalation.
May cause SENSITIZATION by inhalation and skin contact.
Irritating to eyes, respiratory system and skin.
Extremely flammable.
Risk of explosion if heated under confinement.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Not normally a hazard due to physical form of product.  Considered an unlikely route of entry in commercial/industrial environments.  

EYE

  Evidence exists, or practical experience predicts, that the material may cause eye irritation in a substantial number of individuals. Prolonged eye contact may cause inflammation characterized by a temporary redness of the conjunctiva (similar to windburn).  The material may be irritating to the eye, with prolonged contact causing inflammation. Repeated or prolonged exposure to irritants may produce conjunctivitis.  

SKIN

  Skin contact with the material may damage the health of the individual; systemic effects may result following absorption.  This material can cause inflammation of the skin oncontact in some persons.  The material may accentuate any pre-existing dermatitis condition.  Spray mist may produce discomfort.  Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected.  

INHALED

  Inhalation of aerosols (mists, fumes), generated by the material during the course of normal handling, may be harmful.  The material can cause respiratory irritation in some persons. The body's response to such irritation can cause further lung damage.  Inhalation of toxic gases may cause:  ·  Central Nervous System effects including depression, headache, confusion, dizziness, stupor, coma and seizures;  ·  respiratory: acute lung swellings, shortness of breath, wheezing, rapid breathing, other symptoms and respiratory arrest;  ·  heart: collapse, irregular heartbeats and cardiac arrest;  ·  gastrointestinal: irritation, ulcers, nausea and vomiting (may be bloody), and abdominal pain.  WARNING: Intentional misuse by concentrating/inhaling contents may be lethal.  Exposure to Hydrocarbons may result in irregularity of heart beat. Symptoms of moderate poisoning may include dizziness, headache, nausea. Serious poisoning can result in decreased respiratory function, this may lead to unconsciousness and death. C4 hydrocarbons are especially dangerous to the nervous system. Inhalation of petroleum gases (partly due to olefin impurities) can induce sleep. Serious cases can result in cyanosis due to reduced oxygen concentration and hence asphyxiation, with symptoms of fast breathing, mental dullness, inco- ordination, poor judgment, nausea and vomiting; leading to unconsciousness and death.  

CHRONIC HEALTH EFFECTS

  Principal route of occupational exposure to the gas is by inhalation.  Persons with a history of asthma or other respiratory problems or are known to be sensitised, should not be engaged in any work involving the handling of isocyanates. [CCTRADE-Bayer, APMF].  Asthma-like symptoms may continue for months or even years after exposure to the material ceases. This may be due to a non-allergenic condition known as reactive airways dysfunction syndrome (RADS) which can occur following exposure to high levels of highly irritating compound. Key criteria for the diagnosis of RADS include the absence of preceding respiratory disease, in a non-atopic individual, with abrupt onset of persistent asthma-like symptoms within minutes to hours of a documented exposure to the irritant. A reversible airflow pattern, on spirometry, with the presence of moderate to severe bronchial hyperreactivity on methacholine challenge testing and the lack of minimal lymphocytic inflammation, without eosinophilia, have also been included in the criteria for diagnosis of RADS. RADS (or asthma) following an irritating inhalation is an infrequent disorder with rates related to the concentration of and duration of exposure to the irritating substance. Industrial bronchitis, on the other hand, is a disorder that occurs as result of exposure due to high concentrations of irritating substance (often particulate in nature) and is completely reversible after exposure ceases. The disorder is characterised by dyspnea, cough and mucus production.  There has been concern that this material can cause cancer or mutations, but there is not enough data to make an assessment.  Inhaling this product is more likely to cause a sensitization reaction in some persons compared to the general population.  There is limited evidence that, skin contact with this product is more likely to cause a sensitization reaction in some persons compared to the general population.  Respiratory sensitization may result in allergic/asthma like responses; from coughing and minor breathing difficulties to bronchitis with wheezing, gasping.  Isocyanate vapors are irritating to the airways and can cause their inflammation, with wheezing, gasping, severe distress, even loss of consciousness and fluid in the lungs. Nervous system symptoms that may occur include headache, sleep disturbance, euphoria, inco-ordination, anxiety, depression and paranoia. Digestive effects include nausea and vomiting. Breathing difficulties may occur unpredictably after a period of tolerance and after skin contact. Allergic inflammation of the skin can occur, with rash, itching, blistering, and swelling of the hands and feet. Sensitive people can react to very low levels and should not be exposed to this material.  Sensitization may result in allergic dermatitis responses includingrash, itching, hives or swelling of extremities.